Rainbow Seed Fund News

CHAIN announces a new collaboration with clinical researchers at the University of Oxford to develop superior oral vaccines for infectious diseases Marlow, UK- 13th of June 2022- FOR IMMEDIATE RELEASE CHAIN Biotechnology and the University of Oxford plan to collaborate on a two-year project to develop a new type of vaccine to immunise against human […]

read more

Zentraxa are excited to announce capital investment from Future Planet Capital, Bristol Private Equity Club (BPEC) and Science Angel Syndicate to develop their innovative Zentide platform for engineering bespoke biomaterials. With generous support of their recently awarded Innovate UK grant, Zentraxa is rapidly moving towards contracted commercial concept development in both medical adhesives and personal […]

read more

Appoints Industry Veteran Glyn Edwards MBE as Chair Oxford, England, 25 April 2022 – MitoRx Therapeutics (MitoRx), a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction to arrest the progression of degenerative diseases, announces the close of its seed financing. Financial details are not disclosed. The company also announces the appointment of Glyn Edwards […]

read more

1 2 3 15